Icure Pharmaceutical Incorporation 15-day patch manufacturing suspension, KRW 13.9 billion in affected sales
AI summary · Not investment advice
A 15-day patch manufacturing suspension starts 2026.11.18, covering KRW 13.9 billion in sales, 16.77% of revenue.
Revenue of suspended business
KRW 13.9 billion
2025 sales amount of the company's patch products
Key facts
- Suspended business
- Suspension of patch (adhesive plaster) manufacturing operations
- Board resolution date
- Nov 6, 2026Date the administrative disposition notice was received
Commentary
AI commentary · Not investment advice
What happened
iCure received an order to stop manufacturing patch-type products (adhesive patches) for 15 days. The suspension runs from 2026.11.18 to 2026.12.02. The sales tied to this order total KRW 13.89 billion.
In the company's terms
This equals 16.77% of the company's recent total sales of KRW 82.84 billion.
What changes for shareholders
The suspension starts on 2026.11.18, and this schedule is confirmed. The board of directors made its resolution on 2026.11.06.
How is this disclosure for shareholders?
All 1
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
I